Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ARA 290 in rheumatoid arthritis
2010-023469-22Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of cibinetide in rheumatoid arthritis (RA), sponsored by Leiden University Medical Center. Primary endpoint: Safety and tolerability parameters. Started Dec 2010; status: active.
02
Drugs
cibinetide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-023469-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023469-22.